Why the study?
Pathophysiological mechanisms of atrial fibrillation remain unclear, and optimal biomarkers for early detection and prognostic assessment are lacking.
What is the role of microRNAs in the pathophysiology of atrial fibrillation and their potential as diagnostic biomarkers?
What is the role of microRNAs in the pathophysiology of atrial fibrillation and their potential as diagnostic biomarkers?
MicroRNAs are fundamentally involved in the pathophysiology of atrial fibrillation through atrial remodeling and hold promise as diagnostic biomarkers, though precise reference limits remain to be established.
No takes yet. Share an insight, caveat, or question.
MicroRNAs may advance AF biomarker research; leaves open clinical validation and utility.
Chaulin et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: